“Conclusions Based on the results of the present study, it is concluded that PUFAs enhance the tumoricidal action of the anti-cancer drug 5-FU by acting on anti-angiogenic factors and enzymes involved in lipid metabolism.”
“Results It was … combined treatment of 5-FU + PUFAs on gastric carcinoma (MGC and SGC) cells produced a significant growth inhibitory action compared with either agent alone by inhibiting … production of TNF-α and VEGF and a simultaneous increase in the expression of LPL, PPAR-γ, and C/EBP.”